Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 08:35 am Purchase | 2024-12-31 | 13G | Coya Therapeutics, Inc. COYA | Orin Hirschman | 1,333,919 8.000% | 169,547 (+14.56%) | Filing History |
| 2025-02-10 08:33 am Purchase | 2024-12-31 | 13G | Ideal Power Inc. IPWR | Orin Hirschman | 823,315 9.900% | 123,315 (+17.62%) | Filing History |
| 2025-02-10 08:30 am Purchase | 2024-12-31 | 13G | Myomo, Inc. MYO | Orin Hirschman | 3,381,567 9.900% | 543,277 (+19.14%) | Filing History |
| 2025-02-10 08:29 am Sale | 2024-12-31 | 13G | Personalis, Inc. PSNL | Orin Hirschman | 4,293,639 6.100% | -100,425 (-2.29%) | Filing History |
| 2025-02-10 08:27 am Sale | 2024-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Orin Hirschman | 560,905 9.500% | -7,776 (-1.37%) | Filing History |
| 2025-02-10 08:24 am Sale | 2024-12-31 | 13G | Theratechnologies Inc. THTX | Orin Hirschman | 3,026,569 6.100% | -692,733 (-18.63%) | Filing History |
| 2025-02-04 08:53 am Sale | 2024-12-31 | 13G | SmartKem, Inc. SMTK | Orin Hirschman | 362,784 9.900% | -17,417 (-4.58%) | Filing History |
| 2025-02-03 8:07 pm Purchase | 2024-12-31 | 13G | SmartKem, Inc. SMTK | Orin Hirschman | 380,201 9.900% | 243,264 (+177.65%) | Filing History |
| 2025-01-31 4:05 pm Purchase | 2024-12-31 | 13G | Intellicheck, Inc. IDN | Orin Hirschman | 1,617,696 8.200% | 18,743 (+1.17%) | Filing History |
| 2025-01-31 4:05 pm Purchase | 2024-12-31 | 13G | scPharmaceuticals Inc. SCPH | Orin Hirschman | 4,200,577 8.400% | 1,093,782 (+35.21%) | Filing History |
| 2025-01-31 4:05 pm Sale | 2024-12-31 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 206,396 8.500% | -18,202 (-8.10%) | Filing History |
| 2025-01-31 4:05 pm Unchanged | 2024-12-31 | 13G | LightPath Technologies, Inc. LPTH | Orin Hirschman | 3,723,932 9.400% | 0 (Unchanged) | Filing History |
| 2025-01-31 4:05 pm Purchase | 2024-12-31 | 13G | TELA Bio, Inc. TELA | Orin Hirschman | 2,662,785 6.800% | 1,284,840 (+93.24%) | Filing History |
| 2025-01-29 8:02 pm Purchase | 2024-12-31 | 13G | Elutia Inc. ELUT | Orin Hirschman | 3,074,735 9.900% | 1,188,179 (+62.98%) | Filing History |
| 2025-01-29 7:58 pm Purchase | 2024-12-31 | 13G | Biofrontera Inc. BFRI | Orin Hirschman | 884,563 9.900% | 383,129 (+76.41%) | Filing History |
| 2025-01-29 06:17 am Sale | 2024-12-31 | 13G | Immix Biopharma, Inc. IMMX | Orin Hirschman | 0 0.000% | -1,455,000 (Position Closed) | Filing History |
| 2025-01-29 06:13 am Purchase | 2024-12-31 | 13G | Grace Therapeutics, Inc. GRCE | Orin Hirschman | 521,083 5.100% | 521,083 (New Position) | Filing History |
| 2025-01-29 06:11 am Sale | 2024-12-31 | 13G | Electrovaya Inc. ELVA | Orin Hirschman | 2,515,099 6.300% | -838,209 (-25.00%) | Filing History |
| 2025-01-29 06:08 am Purchase | 2024-12-31 | 13G | Arq, Inc. ARQ | Orin Hirschman | 3,012,956 7.200% | 674,220 (+28.83%) | Filing History |
| 2025-01-27 10:07 am Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 67,407 4.900% | -21,337 (-24.04%) | Filing History |